Upcoming Talks on EpiVax Tregitope Technology: a Paradigm Shift

Share Article

EpiVax, a paradigm-shifting biotechnology company, takes the road this fall to share news about Tregitope – the small peptides contained in IgG that trigger regulatory T cells – and other cutting-edge science and technology with scientific colleagues. Starting in Asia, EpiVax will be presenting the Tregitope paradigm shift at high quality, scientific conferences.

News Image

Immunogenicity of Biologics. Industry seminar, participation by invitation - Regulating Immune Response in Biologics- A Paradigm-Shifting Solution? Westin Hotel, Tokyo, Japan Pharmaceutical Association. Contacts: Dr. Keizo Yoshida, yoshidakeizo@gmail.com, Shannon Pelletier, spelletier@epivax.com.

Tokyo, Japan: September 27, 2010. Putting Immunoinformatics to work to develop safer vaccines and improved therapeutics. INCOB Japan. Asian-Pacific Bioinformatics Network. IMMS (International Immunoinformatics Society) session. Click here for the link to InCob conference website.

Chantilly Virginia: September 28, 2010. Invited talk. Preclinical Design of Less Immunogenic Biologics: Tregitopes and Tolerance. 16th International Conference of the Inflammation Research Association. Chantilly Virginia, from September 26-29, 2010. New Technologies session. Andy Glasebrook, Chair. Click here for the link to the Inflammation Research website.

Brussels, Belgium: September 29, 2010 Invited talk. Tregitopes, Immunogenicity and Tolerance. 6th Annual Immunogenicity for Biologics, Sheraton Brussels Hotel, Belgium. 28 - 29 September 2010. Click here for the link to the Immunogenicity for Biologics website.

Amsterdam, the Netherlands: November 30th & December 1st . Invited talk. Immunogenicity in Biologics Session. Regulating Immune Response in Biologics- A Paradigm-Shifting Solution? Vaccine Session. iVAX: Building “Faster, Safer” Vaccines using an Immunoinformatics Toolkit. Advancing Vaccines & Biologics from the lab to the Clinic.

For more information on EpiVax see http://www.EpiVax.com
To schedule Tregitope/Immunogenicity speaking engagements, see spelletier(at)epivax(dot)com


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Annie De Groot
Visit website